Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its peers? We will compare Surgery Partners to related businesses based on the strength of its risk, valuation, analyst recommendations, earnings, dividends, profitability and institutional ownership.
Insider and Institutional Ownership
94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.0% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by company insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares Surgery Partners and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-26.30|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||816.99|
Surgery Partners has higher revenue and earnings than its peers. Surgery Partners is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This table compares Surgery Partners and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||3.45%||3.46%||4.28%|
This is a breakdown of recent ratings for Surgery Partners and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||59||331||513||9||2.52|
Surgery Partners currently has a consensus target price of $18.00, indicating a potential upside of 48.76%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 11.98%. Given Surgery Partners’ higher possible upside, equities analysts plainly believe Surgery Partners is more favorable than its peers.
Risk & Volatility
Surgery Partners has a beta of 1.89, meaning that its stock price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ peers have a beta of 0.87, meaning that their average stock price is 13% less volatile than the S&P 500.
Surgery Partners peers beat Surgery Partners on 8 of the 13 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.